Gujarat Themis Biosyn Limited Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Gujarat Themis Biosyn Limited Company Profile :

Gujarat Themis Biosyn Limited is an Indian company engaged in the business of manufacturing of pharmaceuticals and medicinal chemical products.

The Company’s products include Rifamycin-S, which is an intermediate for Rifampicin for the treatment of tuberculosis (TB), and Lovastatin. The Company’s research and development is focused on developing new fermentation cultures.

The Company’s manufacturing plant is located at Valsad, Gujarat.


Gujarat Themis Biosyn ResultsBSE Code : 506879
NSE Symbol : – 
ISIN No. : INE942C01029
Industry : Pharmaceuticals
Face Value : Rs.5.00


If you are an investor who has shares of Gujarat Themis Biosyn or you are an stock market analyst then i am sure you might for Quarterly Results of Gujarat Themis Biosyn.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Gujarat Themis Biosyn. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Gujarat Themis Biosyn.

Gujarat Themis Biosyn Q1 Results 2016-17 :

Gujarat Themis Biosyn will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT  –
Tax  –
Net Profit  –
Equity  –
EPS  –

Gujarat Themis Biosyn will announce its Q2 FY 2016-17 Results in the month of October 2016.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT  –
Tax  –
Net Profit  –
Equity  –
EPS  –

Gujarat Themis Bios

(Values in Cr.) Q2 Standalone Q2 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT  –
Tax  –
Net Profit  –
Equity  –
EPS  –

Gujarat Themis Biosyn will announce its Q4 FY 2016-17 Results in the month of April 2017.

(Values in Cr.) Q4 Standalone Q4 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT  –
Tax  –
Net Profit  –
Equity  –
EPS  –

Gujarat Themis Biosyn will announce its FY 2016-17 Results in the month of April 2017.

(Values in Cr.) FY 2016-17 Standalone FY 2016-17 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT  –
Tax  –
Net Profit  –
Equity  –
EPS  –

Note : We will update the results table above as and when results are announced. Visit again.

Gujarat Themis Biosyn Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue 32.63
Other Income  0.17
Total Income  32.80
Expenditure  -26.59
Interest  -0.38
Depreciation  -1.20
PBT  4.63
Tax  –  –
Net Profit  4.63  –
Equity  7.26  –
EPS  3.19  –

Note : If you like this information about Gujarat Themis Biosyn Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.